Progesterone ameliorates diabetic nephropathy in streptozotocin-induced diabetic Rats

Diabetology and Metabolic Syndrome

Volumn 7, Issue 1, 2015, Pages

  Al Trad, Bahaa ^a,b   Ashankyty, Ibraheem M ^b,c   Alaraj, Mohd ^b  

^a YARMOUK UNIVERSITY   (Jordan)

^b UNIVERSITY OF HAIL   (Saudi Arabia)

^c KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

Angiogenesis; Angiotensin II type 1 receptor; Diabetic nephropathy; Fibrosis; Progesterone

Indexed keywords

ALBUMIN; ANGIOTENSIN 1 RECEPTOR; CREATININE; FIBRONECTIN; NEPHRIN; PODOCIN; PROGESTERONE; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN A;

ADULT; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DOWN REGULATION; DRUG EFFICACY; FEMALE; GLOMERULOSCLEROSIS; HORMONE SUBSTITUTION; IMMUNOHISTOCHEMISTRY; KIDNEY FIBROSIS; KIDNEY HYPERTROPHY; NONHUMAN; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; RENAL PROTECTION; TREATMENT DURATION; URINE LEVEL;

EID: 84947049412     PISSN: None     EISSN: 17585996     Source Type: Journal    
DOI: 10.1186/s13098-015-0097-1     Document Type: Article

References (38)

1. Marshall SM. Recent advances in diabetic nephropathy. Postgrad Med J. 2004;80:624-33.
2. Wolf G. New insights into the pathophysiology of diabetic nephropathy: from haemodynamics to molecular pathology. Eur J Clin Invest. 2004;34:785-96.
3. Maric C. Sex, diabetes and the kidney. Am J Physiol-Renal Physiol. 2009;296:680-8.
4. Silbiger S, Neugarten J. Gender and human chronic renal disease. Gend Med. 2008;5(SupplA):S3-S10.
5. Yanes LL, Sartori-Valinotti JC, Reckelhoff JF. Sex steroids and renal disease: lessons from animal studies. Hypertension. 2008;51:976-81.
6. Mankhey RW, Bhatti F, Maric C. 17beta-Estradiol replacement improves renal function and pathology associated with diabetic nephropathy. Am J Physiol-Renal Physiol. 2005;288:399-405.
7. Wells CC, Riazi S, Mankhey RW, Bhatti F, Ecelbarger C, Maric C. Diabetic nephropathy is associated with decreased circulating estradiol levels and imbalance in the expression of renal estrogen receptors. Gend Med. 2005;2:227-37.
8. Dixon A, Maric C. 17beta-Estradiol attenuates diabetic kidney disease by regulating extracellular matrix and transforming growth factor-beta protein expression and signaling. Am J Physiol-Renal Physiol. 2007;293:1678-90.
9. Bumke-Vogt C, Bähr V, Diederich S. Expression of the progesterone receptor and progesterone- metabolising enzymes in the female and male human kidney. J Endocrinol. 2002;175:349-64.
10. Antus B, Hamar P, Kokeny G, Szollosi Z, Mucsi I, Nemes Z, et al. Estradiol is nephroprotective in the rat remnant kidney. Nephrol Dial Transplant. 2003;18:54-61.
11. Nielsen CB, Flyvbjerg A, Bruun JM, Forman A, Wogensen L, Thomsen K. Decreases in renal functional reserve and proximal tubular fluid output in conscious oophorectomized rats: normalization with sex hormone substitution. J Am Soc Nephrol. 2003;14:3102-10.
12. Sandhi J, Singh JP, Kaur T, Ghuman SS, Singh AP. Involvement of progesterone receptors in ascorbic acid-mediated protection against ischemia-reperfusion-induced acute kidney injury. J Surg Res. 2014;187:278-88.
13. Montezano AC, Callera GE, Mota AL, Fortes ZB, Nigro D, Carvalho MH, et al. Endothelin-1 contributes to the sexual differences in renal damage in DOCA-salt rats. Peptides. 2005;26:1454-62.
14. Ballester J, Muñoz MC, Domínguez J, Palomo MJ, Rivera M, Rigau T, et al. Tungstate administration improves the sexual and reproductive function in female rats with streptozotocin-induced diabetes. Hum Reprod. 2007;22:2128-35.
15. Khajuria DK, Razdan R, Mahapatra DR. Description of a new method of ovariectomy in female rats. Rev Bras Reumatol. 2012;52:462-70.
16. Kestenbaum B, de Boer IH. Urine albumin-to-creatinine ratio: what's in a number? J Am Soc Nephrol. 2010;21:1243-4.
17. Maric C, Sandberg K, Hinojosa-Laborde C. Glomerulosclerosis and tubulointerstitial fibrosis are attenuated with 17beta-estradiol in the aging Dahl salt sensitive rat. J Am Soc Nephrol. 2004;15:1546-56.
18. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta Delta C(T)) method. Methods. 2001;25:402-8.
19. Singh R, Song RH, Alavi N, Pegoraro AA, Singh AK, Leehey DJ. High glucose decreases matrix metalloproteinase-2 activity in rat mesangial cells via transforming growth factor-beta1. Exp Nephrol. 2001;9:249-57.
20. Harrison-Bernard LM, Imig JD, Carmines PK. Renal AT1 receptor protein expression during the early stage of diabetes mellitus. Int J Exp Diabetes Res. 2002;3:97-108.
21. Xu ZG, Miao LN, Cui YC, Jia Y, Yuan H, Wu M. Angiotensin II type 1 receptor expression is increased via 12-lipoxygenase in high glucose-stimulated glomerular cells and type 2 diabetic glomeruli. Nephrol Dial Transplant. 2009;24:1744-52.
22. Cooper ME, Vranes D, Youssef S, Stacker SA, Cox AJ, Rizkalla B, et al. Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes. Diabetes. 1999;48:2229-39.
23. Xu Q, Prabhu A, Xu S, Manigrasso MB, Maric C. Dose-dependent effects of dihydrotestosterone in the streptozotocin-induced diabetic rat kidney. Am J Physiol Renal Physio. 2009;297:F307-15.
24. Pavenstadt H, Kriz W, Kretzler M. Cell biology of the glomerular podocyte. Physiol Rev. 2003;83:253-307.
25. Kanwar YS, Wada J, Sun L, Xie P, Wallner EI, Chen S, et al. Diabetic nephropathy: mechanisms of renal disease progression. Exp Biol Med (Maywood). 2008;233:4-11.
26. Chen S, Jim B, Ziyadeh FN. Diabetic nephropathy and transforming growth factor-β: transforming our view of glomerulosclerosis and fibrosis build-up. Seminar Nephrol. 2003;23:532-43.
27. Kandasamy AD, Chow AK, Ali MA, Schulz R. Matrix metalloproteinase-2 and myocardial oxidative stress injury: beyond the matrix. Cardiovasc Res. 2010;85:413-23.
28. Leehey DJ, Singh AK, Alavi N, Singh R. Role of angiotensin II in diabetic nephropathy. Kidney Int Suppl. 2000;77:93-8.
29. Opie LH. Renoprotection by angiotensin-receptor blockers and ACE inhibitors in hypertension. Lancet. 2001;358:182-3.
30. Xu ZG, Lanting L, Vaziri ND, Li Z, Sepassi L, Rodriguez-Iturbe B, et al. Upregulation of angiotensin II type 1 receptor, inflammatory mediators, and enzymes of arachidonate metabolism in obese Zucker rat kidney: reversal by angiotensin II type 1 receptor blockade. Circulation. 2005;111:1962-9.
31. Nakagawa T, Kosugi T, Haneda M, Rivard CJ, Long DA. Abnormal angiogenesis in diabetic nephropathy. Diabetes. 2009;58:1471-8.
32. De Vriese AS, Tilton RG, Elger M, Stephan CC, Kriz W, Lameire NH. Antibodies against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes. J Am Soc Nephrol. 2001;12:993-1000.
33. Wen D, Huang X, Zhang M, Zhang L, Chen J, Gu Y, et al. Resveratrol attenuates diabetic nephropathy via modulating angiogenesis. PLoS ONE. 2013;8:e82336.
34. Xu Q, Wells CC, Garman JH, Asico L, Escano CS, Maric C. Imbalance in sex hormone levels exacerbates diabetic renal disease. Hypertension. 2008;51:1218-24.
35. Leaming AB, Mathur RS, Levine JH. Increased plasma testosterone in streptozotocin-diabetic female rats. Endocrinology. 1982;111:1329-33.
36. Satta E, Magno C, Galì A, Inferrera A, Granese R, Aloisi C, et al. Sexual dysfunction in women with diabetic kidney. Int J Endocrinol. 2014;2014:346834.
37. Bargiota A, Dimitropoulos K, Tzortzis V, Koukoulis GN. Sexual dysfunction in diabetic women. Hormones (Athens). 2011;10:196-206.
38. Bargiota A, Dimitropoulos K, Tzortzis V, Koukoulis GN. Sexual dysfunction in diabetic women. Hormones (Athens). 2011;10:196-206.